Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 259

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Clinical Validation of Chemotherapy Response Biomarker ERCC2 in Muscle-Invasive Urothelial Bladder Carcinoma

Open access
Liu, David, Plimack, Elizabeth R., Hoffman-Censits, Jean, Garraway, Levi A., Bellmunt, Joaquim, Van Allen, Eliezer, Rosenberg, Jonathan E.·2016·JAMA Oncology

Abstract

10 PD events were colon and prostate cancer, which were also unrelated to earlier PD (Table 2).Discussion | Both cancer and PD occur primarily at advanced ages and can be debilitating.Consequently, medical surveillance for cancer could be influenced by a prior PD diagnosis, which may bias the observed PD-cancer associations.Moreover, patterns of medical surveillance may differ by health care system (eg, US Medicare and Taiwan National Health Insurance Research Database).It is therefore important that in evaluating PD-cancer associations investigators adjust for medical surveillance and include negative controls.Although we cannot rule out small risks attributable to sample size, we did not find a positive association between PD and subsequent cancer in Asian Americans in SEER-Medicare data.Although according to SEER-Medicare data Asian Americans are ethnically more diverse than the Taiwanese population, our null findings do not support the hypothesis that ethnicity is a major contributor to the elevated risk in the study by Lin et al. 4 The elevated risks observed in the study by Lin et al 4 could reflect various factors, including possibly more cancer surveillance after PD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamaoncol.2016.1056

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 259

Metadata

Authors
Liu, D., Plimack, E. R., Hoffman-Censits, J., Garraway, L. A., Bellmunt, J., Van Allen, E., & Rosenberg, J. E.
Venue
JAMA Oncology
Published
2016-08-01
Volume
2
Issue
8
Pages
1094
ISSN
2374-2437 (ISSN-L)
OpenAlex
W2432541865
Cited by
259
References
2
FWCI
26.22
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical Validation of Chemotherapy Response Biomarker ERCC2 in Muscle-Invasive Urothelial Bladder Carcinoma. https://app.cochat.ai/papers/10.1001/jamaoncol.2016.1056
The paper
Liu, D., Plimack, E. R., Hoffman-Censits, J., Garraway, L. A., Bellmunt, J., Van Allen, E., & Rosenberg, J. E. (2016). Clinical Validation of Chemotherapy Response Biomarker ERCC2 in Muscle-Invasive Urothelial Bladder Carcinoma. JAMA Oncology. https://doi.org/10.1001/jamaoncol.2016.1056

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.